TWSG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.514600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.862600E-01
Normal-vs-Stage2
7.928000E-01
Normal-vs-Stage3
8.142400E-01
Normal-vs-Stage4
6.238600E-01
Stage1-vs-Stage2
3.440200E-01
Stage1-vs-Stage3
9.260800E-01
Stage1-vs-Stage4
2.933600E-01
Stage2-vs-Stage3
5.040400E-01
Stage2-vs-Stage4
5.931400E-01
Stage3-vs-Stage4
4.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.962000E-01
Normal-vs-AfricanAmerican
5.875000E-01
Normal-vs-Asian
9.859800E-01
Caucasian-vs-AfricanAmerican
4.727800E-01
Caucasian-vs-Asian
7.812200E-01
AfricanAmerican-vs-Asian
3.867000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.147000E-01
Normal-vs-Female
7.471800E-01
Male-vs-Female
5.056000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.854000E-01
Normal-vs-Age(41-60Yrs)
4.231800E-01
Normal-vs-Age(61-80Yrs)
9.460000E-01
Normal-vs-Age(81-100Yrs)
5.361400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.086400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.527200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.895200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.063490E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.530030E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.849800E-01
Normal-vs-Daily Drinker
6.694000E-01
Normal-vs-Weekly Drinker
5.178800E-01
Normal-vs-Occasional Drinker
7.522000E-01
Normal-vs-Social Drinker
7.470000E-01
Non Drinker-vs-Daily Drinker
8.783200E-01
Non Drinker-vs-Weekly Drinker
3.452300E-02
Non Drinker-vs-Occasional Drinker
1.888620E-01
Non Drinker-vs-Social Drinker
2.259400E-01
Daily Drinker-vs-Weekly Drinker
4.741800E-02
Daily Drinker-vs-Occasional Drinker
1.621050E-01
Daily Drinker-vs-Social Drinker
1.730850E-01
Weekly Drinker-vs-Occasional Drinker
6.971000E-01
Weekly Drinker-vs-Social Drinker
7.606800E-01
Occasional Drinker-vs-Social Drinker
9.564600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.104400E-01
Normal-vs-Grade 2
9.554000E-01
Normal-vs-Grade 3
9.400200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.721700E-02
Grade 1-vs-Grade 3
7.687500E-02
Grade 1-vs-Grade 4
8.104400E-01
Grade 2-vs-Grade 3
7.822200E-01
Grade 2-vs-Grade 4
9.554000E-01
Grade 3-vs-Grade 4
9.400200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.340800E-01
Normal-vs-NonDiabetic
8.690800E-01
Diabetic-vs-NonDiabetic
4.315200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.330000E-01
Normal-vs-NoPancreatitis
8.704000E-01
Pancreatitis-vs-NoPancreatitis
4.800400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.856200E-01
Normal-vs-N1
7.655000E-01
N0-vs-N1
2.907200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.659600E-01
Normal-vs-TP53-NonMutant
6.857400E-01
TP53-Mutant-vs-TP53-NonMutant
7.254000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
